Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

IJMDC. 2024; 8(11): 3156-3160


Improvement after tacrolimus ointment in patients with vernal keratoconjunctivitis

Talal A. Althomali, Lara E. Alsulimany, Yousef H. Sabbagh, Ghadi A. Althobaiti, Abdullah A. Alharbi, Rayan A. Alolayani, Raghad A. Almansouri.




Abstract

Objective: The current study aimed to assess the efficacy of tacrolimus ointment in improving symptoms and visual acuity among vernal keratoconjunctivitis (VKC) patients in Taif City, Saudi Arabia.
Methods: This was a retrospective study. Data were collected from the medical files in Tadawi Surgical Medical Complex.
Result: A total of 33 patients with VKC were treated with tacrolimus ointment. Improvement was observed in 21 patients (63.6%), one patient (3%) relapsed after initial improvement, three patients (9.1%) showed no improvement, one patient (3%) was non-compliant, and six patients (18.2%) had no follow-up data. Complications occurred in five patients (15.2%), with redness reported in three cases (60%), hyperemia and injection in one case (20%), and one case relapsing after stopping the medication. Most patients (66.7%) experienced no complications.
Conclusion: Tacrolimus ointment significantly improved symptoms in vernal VKC, with about two-thirds of patients improving. This aligns with findings from other studies demonstrating its efficacy and safety over both short- and long-term use. While some patients reported minor side effects such as redness and itching, the treatment was generally well-tolerated. Relapse rates were low, and tacrolimus was effective even in severe VKC cases where other treatments failed. These results support tacrolimus ointment as a viable option for managing VKC.

Key words: Vernal keratoconjunctivitis, tacrolimus, efficacy, improvement, Saudi Arabia






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.